The case for treatment of dyspeptic patients infected with H. pylori

European Journal of Surgery, Supplement

Volumn 164, Issue 582, 1998, Pages 6-10

  Hunt, Richard H ^a   Huang, Jia Qing ^b  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b NONE

Author keywords

Dyspepsia; H. pylori; Non ulcer dyspepsia

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; CHRONIC GASTRITIS; COST EFFECTIVENESS ANALYSIS; DYSPEPSIA; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH LYMPHOMA; GASTRITIS; HELICOBACTER INFECTION; MICROBIOLOGY; STOMACH TUMOR;

DYSPEPSIA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; STOMACH NEOPLASMS;

EID: 0032216782     PISSN: 1102416X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. 1. Abu-Mahfouz MZ, Prasad VM, Santogade P, Cutler AF. Helicobacter pylori recurrence after successful eradication: 5-year follow-up in the United States. Am J Gastroenterol 1997; 92: 2025-2028.
2. 2. Armstrong D, Hunt RH. Helicobacter pylori and dyspepsia: a conceptual approach. In: Hunt RH, Tytgat GNJ (eds). Helicobacter pylori Basic Mechanisms to Clinical Cure 1996. London: Kluwer Academic Publishers, 1996: 324-339.
3. 3. Axon A, Forman D. Helicobacter gastroduodenitis: a serious infectious disease. BMJ 1997; 314: 1330-1331.
4. 4. Barbara G, Vallance BA, Collins SM. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997; 113:1224-1232.
5. 5. Blaser MJ, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994; 94: 4-8.
6. 6. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter pylori Study Group. Gut 1997; 41: 8-13.
7. 7. Di Mario F, Dal Bo N, Bortolon M, et al. Helicobacter pylori eradication in functional dyspepsia: a prospective randomized six months study. Gastroenterology 1997; 112: A103.
8. 8. Fendrick AM, Chernew ME, Hirth RA, Bloom BS. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995; 123: 260-268.
9. 9. Forman D, Webb P, Parsonnet J. H. pylori and gastric cancer. Lancet 1994; 343: 243-244.
10. 10. Fraser AG, Ali MR, McCullough S, Yeates NJ, Haystead A. Diagnostic tests for Helicobacter pylorican they help select patients for endoscopy? N Z Med J 1996; 109: 95-98.
11. 11. Hovelius B, Andersson SI, Hagander B, et al. Dyspepsia in general practice: history and symptoms in relation to Helicobacter pylori serum antibodies. Scand J Gastroenterol 1994; 29: 506-510.
12. 12. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between H. pylori seropositivity and gastric cancer (GC). Gastroenterology 1998; 114: 1169-1179.
13. 13. Huang JQ, Chen Y, Wilkinson J, Hunt RH. Does initial choice of Helicobacter pylori (HP) treatment regimen influence the recurrence rate of duodenal ulcer (DU)? A meta-analysis. Am J Gastroenterol 1996; 91: 1914. (abstract).
14. 14. Huang JQ, Sheldon A, Hunt RH. Is there a causal relationship between H. pylori infection and gastric Maltoma? A meta-analysis of evidence from epidemiological studies and clinical trials. Gut 1997; 41 (Suppl 1): A49.
15. 15. Hunt RH. The role of Helicobacter pylori in pathogenesis: the spectrum of clinical outcomes. Scand J Gastroenterol 1996; Suppl 220: 3-9.
16. 16. Ihezue CH, Oluwole FS, Onuminya JE, Okoronkwo MO. Dyspepsias among the highlanders of Nigeria: an epidemiological survey. Afr J Med Sci 1996; 25: 23-29.
17. 17. International Agency for Research on Cancer Schistosomes, liver flukes and Helicobacter pylori IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 61. Lyon, France: IARC, 1994.
18. 18. Jaspersen D. Helicobacter pylori eradication: the best long-term prophylaxis for ulcer bleeding recurrence? Endoscopy 1995; 27: 622-625.
19. 19. Katelaris PH, Tippett GH, Norbu P, Lowe DG, Brennan R, Farthing MJ. Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut 1992; 33: 1162-1466.
20. 20. Knill-Jones RP. Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol 1991; Suppl 182: 17-24.
21. 21. Kuipers EJ, Thijs JC, Festen HPM. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995; 9 (Suppl 2): 59-69.
22. 22. Laheij RJF, Jansen JBMJ, van de Lisdonk EH, Severens JL, Verbeek ALM. Review article: symptom improvement through eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 1996; 10: 843-850.
23. 23. McCarthy C, Patchett S, Collins RM, Beattie S, Keane C, O'Morain C. Long-term prospective study of Helicobacter pylori in non-ulcer dyspepsia. Dig Dis Sci 1995; 40: 114-119.
24. 24. McColl KE, el-Nujumi A, Murray L, et al. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997; 40:302-306.
25. 25. McColl KEL, El-Nujumi A, El-Omar E, Dickson A. Evidence supporting a H. pylori test and treat strategy for simple dyspepsia. Gastroenterology 1996; 110: A28.
26. 26. Mitchell HM, Hu PJ, Chen MH, Chi Y, Li YY, Hazell SL. Low rate of reinfection in duodenal ulcer patients from a country with high prevalence of H. pylori infection. Gut 1997; 41 (Suppl. 1): A34.
27. 27. Neugut AI, Hayek M, Howe G. Epidemiology of gastric cancer. Seminars in Oncology 1996; 23: 281-291.
28. 28. Ofman JJ, Etchason J, Fullerton S, Kahn KL, Soll AH. Management strategies for Helicobacter pylori-sero-positive patients with dyspepsia: clinical and economic consequences. Ann Intern Med 1997; 126: 280-291.
29. 29. Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trial. Lancet 1996; 348: 150-154.
30. 30. Peek Jr RM, Moss SF, Tham KT, Perez-Perez GI, Wang S, Miller GC, Atherton JC, Holt PR, Blaser MJ. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst 1997; 89: 863-868.
31. 31. Penston JG, Pounder RE, A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996; 10: 83-89.
32. 32. Riemann JF, Schilling D, Schauwecker P, Wehlen G, Dorlar D, Kohler B, Maier M. Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding. Gastrointest Endosc 1997; 469: 299-304.
33. 33. Ruiz B, Rood JC, Fontham ET, et al. Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol 1994; 89: 533-539.
34. 34. Santander C, Gravalos RG, Gomez-Cedenilla A, Cantero J, Pajares JM. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. Am J Gastroenterol 1996; 91: 1549-1552.
35. 35. Sheu BS, Lin CY, Lin XZ, Shiesh SC, Yang HB, Chen CY. Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: A prospective controlled assessment. Am J Gastroenterol 1996; 91: 441-447.
36. 36. Stolte M, Morgner A, Meining A, et al. Clinical presentation, diagnosis and treatment of Helicobacter pylori-related gastric lymphoma. In: Hunt RH, Tytgat GNJ (eds). Helicobacter pylori Basic Mechanisms to Clinical Cure 1996. London: Kluwer Academic Publishers, 1996: 222-231.
37. 37. Tait CL, Jones RH. Helicobacter pylori: a test and treat strategy in primary care. Gastroenterology 1997; 112: A46.
38. 38. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994; 106: 1174-1183.
39. 39. Talley NJ, Colin-Jones D, Koch KL, Koch M, NyrÈn O, Stanghellini V. Functional dyspepsia: a classification with guidelines for management. Gastroenterol Int 1991; 4: 145-160.
40. 40. Talley NJ, Fett SL, Zinsmeister AR, Melton 3rd LJ. Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology 1994; 107: 1040-1049.
41. 41. Talley N, Hunt RH. What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms. Gastroenterology 1997; 113: S67-S77.
42. 42. Talley NJ, Zinsmeister AR, Schleck CD, Melton 3rd LJ. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259-1268.
43. 43. Trespi E, Broglia F, Villani L, Luinetti O, Fiocca R, Solcia E. Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication. Scand J Gastroenterol 1994; 29: 884-888.
44. 44. Tucci A, Corinaldesi R, Stanghellini V, et al. Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 1992; 103: 768-774.
45. 45. Van der Ende A, van der Hulst RW, Dankert J, Tytgat GN. Reinfection versus recrudescence in Helicobacter pylori infection. Aliment Pharmacol Ther 1997; 11 Suppl 1: 55-61.
46. 46. Van der Hulst RW, Rauws EA, Koycu B, et al. Helicobacter pylori reinfection is virtually absent after successful eradication. J Infect Dis 1997; 176: 196-200.
47. 47. Veldhuyzen van Zanten SJO, Malatjalian D, Tanton R, Leddin D, Hunt RH, Blanchard W, et al. The effect of eradication of Helicobacter pylori (Hp) on symptoms of non-ulcer dyspepsia (NUD): a randomized double-blind placebo controlled trial. Gastroenterology 1995; 108: A250.
48. 48. Vermillion DL, Ernst PB, Scicchitano R, Collins SM. Antigen-induced contraction of jejunal smooth muscle in the sensitized rat. Am J Physiol 1988; 255: G701-708.
49. 49. Xia HX, Talley NJ, Keane CT, O'Morain CA. Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes. Dig Dis Sci 1997; 42: 1821-1834.